FDA Approved: KLONOPIN — Supplemental Application (H2-Pharma, LLC)

View source ↗

Summary

FDA approved a supplemental NDA for KLONOPIN (clonazepam) submitted by H2-Pharma, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorder
• Epilepsy
• Panic Disorder

Drugs mentioned

• KLONOPIN (clonazepam)

Snippet

SUPPL AP for KLONOPIN (CLONAZEPAM)